Morgan Stanley’s Spectranetics Corp SPNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-51,805
| Closed | -$1.99M | – | 6752 |
|
|
2017
Q2 | $1.99M | Sell |
51,805
-30,587
| -37% | -$882K | ﹤0.01% | 3800 |
|
|
2017
Q1 | $2.4M | Sell |
82,392
-63,489
| -44% | -$1.69M | ﹤0.01% | 3647 |
|
|
2016
Q4 | $3.57M | Buy |
145,881
+112,066
| +331% | +$2.64M | ﹤0.01% | 3335 |
|
|
2016
Q3 | $848K | Sell |
33,815
-29,178
| -46% | -$681K | ﹤0.01% | 4148 |
|
|
2016
Q2 | $1.18M | Buy |
62,993
+18,706
| +42% | +$329K | ﹤0.01% | 3852 |
|
|
2016
Q1 | $643K | Sell |
44,287
-29,807
| -40% | -$413K | ﹤0.01% | 4266 |
|
|
2015
Q4 | $1.12M | Buy |
74,094
+57,376
| +343% | +$757K | ﹤0.01% | 3979 |
|
|
2015
Q3 | $196K | Sell |
16,718
-1,677
| -9% | -$30K | ﹤0.01% | 5095 |
|
|
2015
Q2 | $423K | Sell |
18,395
-4,640
| -20% | -$130K | ﹤0.01% | 4831 |
|
|
2015
Q1 | $800K | Buy |
23,035
+6,002
| +35% | +$204K | ﹤0.01% | 4304 |
|
|
2014
Q4 | $589K | Sell |
17,033
-19,740
| -54% | -$615K | ﹤0.01% | 4551 |
|
|
2014
Q3 | $976K | Buy |
36,773
+17,351
| +89% | +$466K | ﹤0.01% | 4044 |
|
|
2014
Q2 | $444K | Sell |
19,422
-5,332
| -22% | -$124K | ﹤0.01% | 4672 |
|
|
2014
Q1 | $751K | Buy |
24,754
+2,661
| +12% | +$72.9K | ﹤0.01% | 4241 |
|
|
2013
Q4 | $553K | Sell |
22,093
-92,289
| -81% | -$1.98M | ﹤0.01% | 4383 |
|
|
2013
Q3 | $1.92M | Buy |
114,382
+50,147
| +78% | +$875K | ﹤0.01% | 3253 |
|
|
2013
Q2 | $1.2M | Buy |
+64,235
| New | +$1.22M | ﹤0.01% | 3575 |
|
Morgan Stanley's SPNC Position: Q3 2017 in Review
Morgan Stanley sold out of Spectranetics Corp (SPNC) in Q3 2017, closing a stake of 51,805 shares — an estimated $1.99M sold.
Morgan Stanley first reported a position in SPNC in Q2 2013 and held it in 17 quarters. The position peaked at $3.57M in Q4 2016. 0 funds tracked by Wall St. Rank hold SPNC as of Q3 2017.
- Morgan Stanley reported no remaining Spectranetics Corp position as of Q3 2017 after selling out during the quarter.
- Morgan Stanley sold 51,805 Spectranetics Corp shares in Q3 2017, an estimated $1.99M.
- Morgan Stanley first reported a position in Spectranetics Corp in Q2 2013 and held it in 17 quarters.
- Morgan Stanley's Spectranetics Corp position peaked at $3.57M in Q4 2016.
- 0 funds tracked by Wall St. Rank held Spectranetics Corp as of Q3 2017.
Based on Morgan Stanley's 13F filing for Q3 2017, filed 14 Nov 2017.